Auriga Laboratories(TM), Inc. (OTCBB:ARGA), a specialty pharmaceutical company committed to high-growth revenues through acquisition of valuable brand portfolios and innovative drug development programs, invites investors to review audio and written transcripts of a recent investor conference call in which Philip S. Pesin, Chairman and Chief Executive Officer of Auriga, discussed recent events and progress.
